GeneBio Systems
Recombinant AKT1 Monoclonal Antibody
Recombinant AKT1 Monoclonal Antibody
SKU:AN301428L
Couldn't load pickup availability
Size::50μL
Storage:Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping:Ice bag
Exp date:12 months
Category ID_II:Primary Antibodies
Category ID_III:Monoclonal Antibodies;Recombinant Antibodies
Abbreviation:AKT1
Target Synonym:CWS;MGC;AKT serine/threonine kinase;AKT;CWS6;PKB;PKB-ALPHA;PRKBA;RAC;RAC-ALPHA;AKT1;AKT 1;AKT serine/threonine kinase 1;AKT1_HUMAN;MGC99656;Protein kinase B;Protein Kinase B Alpha;Proto-oncogene c-Akt;RAC Alpha;RAC-alpha serine/threonine-protein kinase;RAC-PK-alpha;AKT;AKT serine/threonine kinase 1;CWS6;PKB;PKB-ALPHA;PRKBA;RAC;RAC-ALPHA
Research Areas:Signal Transduction;Epigenetics and Nuclear Signaling;Cancer;Metabolism;Neuroscience
Conjugation:Unconjugated
Host:Rabbit
Species reactivity:Human;Rat;Mouse
Application:WB;IHC
Isotype:IgG,κ
Clonality:Monoclonal;Recombinant
Clone NO.:A123
UNIProt ID:P31749
Accession:
Background:The serine-threonine protein kinase AKT1 is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery.
Concentration:1 mg/mL
Immunogen:Recombinant human AKT1 fragment
Buffer:PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Purification method:Protein A purified
Dilution:WB 1:500-1:1000;IHC 1:50-1:100
Calculated MW:60 kDa
ObservedMW:60 kDa
